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Neurological consequences of systemic inflammation 
in the premature neonate
Introduction
Premature birth occurs in 10% of pregnancies in the United 
States (Centers for Disease Control and Prevention (CDC), 
2015) and 5–18% of pregnancies across 184 countries world-
wide (Blencowe et al., 2012). Neurodevelopmental impair-
ment such as cerebral palsy (prevalence 5–10%) and cogni-
tive and behavioral deficits (prevalence 40–50%) are a major 
cause of morbidity in survivors of prematurity (Gargus et al., 
2009; Stoll et al., 2010). Despite major progress in neonatal 
care over the last two decades and improved survival rates 
for extremely premature infants (born at gestational age ≤ 28 
weeks), premature infants continue to contribute inordinate-
ly to the burden of early childhood morbidity and long term 
neurodevelopmental disability (Saigal and Doyle, 2008). The 
goals of this article are to provide a brief review of current 
literature with respect to the contribution of inflammatory 
pathways in preterm infant brain injury risks and outcomes.
The Association between Perinatal 
Inflammatory States and Neurodevelopmental 
Impairment
The profound vulnerability of the developing brain to cumula-
tive insults by inflammatory, hypoxic-ischemic and metabolic 
processes in the perinatal period is a primary component of 
brain injury in prematurity (Volpe, 2009). Infections, whether 
congenital or iatrogenic, are a frequent complication in pre-
mature infants. The risk of developing serious life threatening 
blood stream infection increases with decreasing birth weight 
and gestational age. In addition, a considerable number 
(25–60%) of extremely premature infants develop at least one 
invasive bacterial infection during their neonatal intensive 
care hospitalization, with recurrent infections being common 
among many premature neonates (Stoll et al., 2010).
Chorioamnionitis diagnosed clinically or histologically is 
an important cause of premature birth. Presence of histolog-
ic evidence of chorioamnionitis has been shown in 65% of 
placentae in deliveries done at 23–24 weeks of gestational age 
and can be detected in 30% placentae delivered at 29 weeks 
of gestation (Lahra and Jeffery, 2004). Presence of intrauter-
ine infection does not always translate to early onset sepsis 
in preterm neonates. However, it could lead to activation of 
a fetal inflammatory response which may be associated with 
cerebral white matter injury and later neurodevelopmental 
impairment (Wu and Colford, 2000; Yoon et al., 2003). Recent 
reports have demonstrated that any form of systemic inflam-
mation such as clinical sepsis or culture proven sepsis, menin-
gitis with or without bacteremia, bronchopulmonary dysplasia 
(BPD) and necrotizing enterocolitis (NEC) were all associated 
with impaired growth and increased risk of adverse neurologic 
sequelae in premature infants (Stoll et al., 2004; Schlapbach 
et al., 2011; Mitha et al., 2013). Interestingly, it has also been 
reported that late onset sepsis in preterm infants and recurrent 
neonatal blood stream infections even without evidence of 
meningitis are associated with increased risk of progressive ce-
rebral white matter injury and acute changes in cerebral func-
tion indicated by burst suppression pattern on electrographic 
studies (Glass et al., 2008; Helderman et al., 2010), pointing to 
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systemic inflammation from the blood stream infection likely 
contributing to collateral brain damage.
BPD, which is characterized by arrested alveolar growth 
and lung inflammation defined as supplemental oxygen 
administration at 36 weeks of postmenstrual age for prema-
ture infants < 32 weeks of gestation, is known to have a high 
incidence (55%) in infants born at or < 26 weeks in a recent 
report of morbidities in prematurity (Stoll et al., 2015) that 
continues to increase as more extremely low birth weight in-
fants weighing less than 1,000 g (ELBW) are surviving. BPD 
is a notable precedent of impaired neurodevelopmental and 
adverse motor outcomes that is independently associated 
with cognitive impairment in ELBW infants (Natarajan et 
al., 2012). In another recent cohort, prolonged dependence 
on mechanical ventilation at 36 weeks of postmenstrual age, 
often seen in infants with severe BPD, substantially increased 
the risk of quadriparesis and diparesis by 6 fold and 4 fold 
respectively (Van Marter et al., 2011).
Significant neurologic, cognitive and behavioral problems 
are common sequelae of serious central nervous system (CNS) 
lesions of prematurity such as severe grade intraventricular 
hemorrhage with post hemorrhagic ventricular dilatation, 
hemorrhagic parenchymal infarction or cystic periventricular 
leukomalacia (PVL). However, the majority of premature in-
fants exhibiting neurocognitive deficits do not manifest such 
patterns of injury, suggesting that there may be other alter-
ations, insults and remodeling in the developing premature 
brain resulting in more diffuse injury. Serial brain magnetic 
resonance imaging (MRI) data from a cohort of 119 prema-
ture babies born less than 30 weeks of gestation showed that 
at least 50% of babies manifest some degree of cerebral white 
matter injury which accounts for the majority of neurological 
deficits seen in survivors of prematurity (Dyet et al., 2006). 
Such cerebral white matter injury characterized by loss of 
myelination of oligodendrocytes is the predominant form of 
brain injury seen in premature brain and is associated with 
high incidence of neurodevelopmental impairment (Khwaja 
and Volpe, 2008). The exclusive developmental anatomy of 
the premature brain and its exposure to the abnormal ambi-
ence of extrauterine preterm life makes it particularly vulner-
able to damage. Systemic inflammatory insults, such as those 
described in the previous paragraphs, are common phenom-
ena in premature babies. Systemic inflammation activates a 
cascade of pro-inflammatory cytokines in circulation which 
leads to activation of microglia locally in the brain along with 
free radical attack by reactive oxygen and nitrogen species 
resulting in maturation dependent cell death and apoptosis of 
neural cells. Further definition of mechanisms that cause such 
collateral brain injury will hopefully lead to prevention strate-
gies in these settings of systemic inflammatory states.
The Impact of Systemic Inflammation on 
Premature Brain: Potential Mechanisms of 
Brain Injury
Cytokine driven tissue injury
The pathophysiology of systemic inflammation in a preterm 
neonate involves a complex interplay between innate host 
defense and an impaired adaptive immune response of a de-
veloping fetus challenged too early to extrauterine life with 
precipitous exposures to various new antigens they are not 
prepared to respond against. Microorganisms express pre-
served sequences of pathogen associated molecular patterns 
(PAMPs) such as lipopolysaccharides (LPS) or double strand-
ed RNA which can be recognized by human cells through 
pattern recognition receptors such a Toll-like receptors (TLR) 
in clinical conditions such as sepsis and bacteremia (Wynn 
and Levy, 2010). A cascade of reactions are generated when 
the neonate’s immune system recognizes such pathogens that 
ultimately lead to activation of pro-inflammatory cytokines 
and chemokines such as tumor necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and IL-6 (Janeway and Medzhitov, 
2002; Weighardt and Holzmann, 2007). The adaptive immune 
response in premature babies is unique because compared to 
adults, there is dampened production of T-helper 1 (Th1) po-
larizing cytokines such as TNF-α, IL-1β, interferon-γ (IFN-γ) 
and IL-12 and robust production of T-helper 2 (Th2) polariz-
ing cytokines leading to increased susceptibility to infections 
(Sadeghi et al., 2007; Wynn et al., 2008). This in turn incites 
dysregulation of inflammatory reactions of the premature in-
fant leading to a pro-inflammatory state. 
Cytokines may gain access to the CNS by blood borne 
routes or by endogenous production from immune cells, 
brain endothelial cells, microglia, astrocytes and neurons 
(Sebire et al., 1993; Banks, 2005). Elevated levels of circulat-
ing cytokines in premature neonates were evidenced in cord 
blood, amniotic fluid, cerebrospinal fluid and cerebral paren-
chyma of infants diagnosed with inflammation related white 
matter lesions speaking to potentially direct damage by the 
systemic cytokines (Yoon et al., 1996, 1997; Martinez et al., 
1998). While there is no clear correlation between cytokine 
profile in plasma and cerebrospinal fluid (CSF) of preterm 
neonates in response to systemic inflammation or infection, 
systemic inflammation certainly appears to be associated with 
premature brain injury (Ellison et al., 2005). 
Cytokines may also activate local immune cells in the pre-
mature brain. Astrocytes and microglia are the two primary 
CNS cell types which are involved in intracerebral immune 
interactions by secretion of cytokines and chemokines. As-
trocytes, microglia and oligodendrocyte progenitor cells also 
express and are activated by cytokine specific receptors such 
as IL-1β and IFN-γ receptors (Vela et al., 2002). Various 
cytokines particularly TNF-α and IFN-γ have been isolated 
directly in neonatal PVL and white matter lesions expressed 
specifically in microglia/macrophages and astrocytes respec-
tively (Kadhim et al., 2001; Folkerth et al., 2004) with degree 
of expression correlating with severity of oxidative damage 
on histopathological studies (Folkerth et al., 2004). Immu-
nohistochemistry staining of preterm infant autopsy brain 
specimens have demonstrated oxidative and nitrative dam-
age in primarily progenitor premyelinating oligodendrocytes 
in white matter lesions of the immature brain (Haynes et al., 
2003; Back et al., 2005). CSF data followed in a longitudinal 
study of premature very low birth weight (VLBW) infants 
also support the role of oxidative damage and elevated lev-
els of oxidative products in CSF of preterm infants with 
brain MRI evidence of white matter injury at term gestation 
compared to premature infants without evidence of white 
matter lesions on MRI (Inder et al., 2002). The extent of the 
involvement of local microglia in such inflammation asso-
ciated preterm brain injury may be related to its unique de-
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velopmental or maturation dependent location. Recent brain 
autopsy studies have ascertained presence of microglia in the 
human forebrain starting from 16-22 weeks of gestation with 
heavy localization in the cerebral white matter (Rezaie et al., 
2005; Monier et al., 2006). The density of microglia reaches 
its peak in the third trimester which is the period for intense 
susceptibility for the preterm brain to develop white matter 
injury with significant decline in density at term gestation 
(Billiards et al., 2006). 
The current evidence and observations suggest that an ac-
tive fetal cerebral immune response resulting in excitotoxic-
ity and free radical attack, secondary to systemic inflamma-
tory insult rather than actual passage of pathogens into the 
developing CNS is likely the key pathogenesis for cerebral 
damage in premature infants (Figure 1).
Alteration of blood-brain barrier (BBB) function
The BBB and blood cerebrospinal fluid barrier (BCSFB) are 
two major interfaces which play a critical role in separating 
the brain parenchyma from systemic circulation, thereby pre-
serving and maintaining a normal physiologic environment 
paramount for optimal brain growth and function. The BBB 
is a highly selective diffusion barrier composed of specialized 
endothelial cells interconnected by an elaborate network of 
complex tight junction proteins in a basal lamina containing 
pericytes and perivascular antigen presenting cells enveloped 
by perivascular astrocytes (Abbott et al., 2010). Contrary to old 
reports of BBB being under developed in fetuses and neonates, 
the selective function of the BBB is effective from very early 
stages of brain development. It is demonstrated by exclusion 
of passage of proteins and small lipid insoluble molecules be-
tween systemic circulation and brain extracellular fluid with a 
characteristic maturation dependent decline in permeability as 
the brain develops (Saunders et al., 1999, 2000). Animal stud-
ies in fetal and newborn rats and opossums showed increased 
permeability of the BBB (not BCSFB) to plasma proteins spe-
cifically acute phase reactants, IL-1β and TNF-α in response to 
LPS induced systemic inflammation during a restricted period 
of postnatal brain development in both species. This was deter-
mined immunocytochemically by the presence of related pro-
teins in surrounding cerebral blood vessels and brain paren-
chyma involving particularly the cerebral white matter (Stolp 
et al., 2005) again highlighting the location specific nature of 
perinatal brain injury in association with systemic inflamma-
tion in prematurity.
The BBB is a dynamic regulatory structure the organization 
or function of which may be altered by circulating cytokines, 
chemokines or chemical secreted by cells constituting the BBB 
itself. Agents associated with altered BBB integrity in adults 
with neurodegenerative diseases or stroke are bradykinin, 
histamine, serotonin, glutamate, adenosine, platelet activating 
factor, prostaglandins, leukotrienes, interleukins (IL-1β, IL-
1α, IL-6), TNF-α, macrophage inhibitory proteins, matrix 
metalloproteinases, free radicals and nitric oxide, many of 
which are upregulated during and after infections and sys-
temic inflammatory states (Abbott et al., 2006). Disordered 
function of BBB may be a result of systemic or locally secreted 
cytokines altering saturable transporter mechanisms (Xaio et 
al., 2001) or adenosine trisphosphate dependent efflux pump 
activity of the BBB (Bauer et al., 2007) and not truly compro-
mising its structural integrity. Hence it is possible that local-
ized or systemic inflammatory response in fetuses or prema-
ture neonates remote from the CNS may result in increased 
cytokine admittance to the CNS by disruption of BBB/BCSFB 
function. Since there is some indication from animal studies 
that such alteration of BBB may be brain maturation or loca-
tion specifically white matter related, identification of periods 
in brain development when the fetal or premature CNS is 
most vulnerable to inflammatory insult induced damage is of 
paramount importance to determine the therapeutic window 
for any pharmacologic intervention against such brain injury.
Impaired cerebrovascular autoregulation
It is unclear what role hypotension, cardiovascular instabil-
ity, and/or impairment of cerebrovascular autoregulation 
in response to systemic cytokine surge and brain ischemia 
play in sepsis and fetal inflammatory states. Many premature 
infants suffer from hypotension and need inotropic support 
during systemic inflammatory conditions such as sepsis and 
necrotizing enterocolitis (NEC). Interestingly, decreased 
systemic blood pressure may not correlate with decreased 
cerebral blood flow (Volpe, 2008) and pressure passive ce-
rebral circulation is common in sick premature babies (Soul 
et al., 2007). However, cytokinemia associated with systemic 
inflammatory states and infection in premature infants may 
blunt cerebral vascular auto regulatory mechanisms in the 
developing brain and augment an otherwise weak hypox-
ic-ischemic insult to a potent damaging one (Ikeda et al., 
2004; Larouche et al., 2005; Wang et al., 2007).
Diagnostic Imaging and Biomarkers of 
Perinatal White Matter Injury in Premature 
Infants
Biomarkers with accurate diagnostic and prognostic poten-
tial are needed for differentiating between infants who have 
significant neuroinflammation and white matter injury as-
sociated with chances of permanent sequelae from the ones 
who might benefit from therapeutic interventions. The Ex-
tremely Low Gestational Age Newborn (ELGAN) study for e 
newborns at extremely low gestational age demonstrated that 
serial measurements of plasma levels of vascular endotheli-
al growth factor receptor 1, serum amyloid A, macrophage 
inflammatory protein 1β on day of life 1 and IL-8 on day of 
life 7 in extremely premature infants were associated with in-
creased risk ventriculomegaly and diffuse white matter chang-
es on brain MRI (Leviton et al., 2011). Even though plasma 
cytokine levels for prediction of white matter injury seems to 
have diagnostic value, earlier studies have failed to establish a 
correlation between plasma and CSF cytokine levels further 
implying that certain cytokines such as IL-8 may achieve 
higher levels in CSF than in plasma which may be more pre-
dictive of MRI-defined white matter injury related to systemic 
infection or inflammation in premature newborns (Ellison 
et al., 2005). Hence, overt reliance on plasma cytokine levels 
may delay or prevent early recognition of neurological conse-
quences of systemic inflammatory states. Currently, cytokines 
are not routinely measured in a neonatal intensive care unit 
(NICU) setting in preterm inflammatory conditions and will 
necessitate cost effective standardized validated assay meth-
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ods prior to integration into standard NICU practice.
The use of neonatal brain MRI is a safe technique to study 
in vivo brain development and has lead way for research in se-
quelae of premature birth and prematurity related comorbid-
ities on the developing brain. Traditionally brain ultrasound 
imaging has been used routinely in NICU practice for serial 
monitoring of germinal matrix hemorrhage, intraventricu-
lar hemorrhage and its complications and detection of PVL. 
Although these are well recognized causes of motor and neu-
rodevelopmental impairment in premature babies these are 
not the predominantly noted brain lesions on MRI imaging 
of premature babies. In a cohort of 119 VLBW babies, only 
2 infants were noted to have evidence of PVL on brain MRI 
whereas 26 babies had punctate lesions in the white matter 
and 70 had diffuse excessive high signal intensity (DEHSI) 
at term equivalent age (Dyet et al., 2006). The etiology and 
clinical relevance of these newly recognized brain lesions us-
ing advanced MRI techniques are still to be elucidated. Some 
authors have hypothesized that such punctate white matter 
lesions and DEHSI in preterm population represent activated 
microglia and hence may indicate an association with sepsis, 
systemic infections or chronic lung disease of prematurity 
(Anjari et al., 2009; Rutherford et al., 2010). 
Some authors have reported long term follow up stud-
ies on cohorts of premature VLBW infants to determine if 
moderate to severe white matter abnormalities and DEHSI 
noted on brain MRI are anatomic antecedents of neurologi-
cal impairments in children born prematurely. In a study of 
167 very premature infants (born < 30 weeks of gestation), 
the presence of any white matter abnormality or moderate 
to severe white matter abnormalities on MRI were noted 
to be more sensitive although less specific than ultrasound 
findings in identifying children who had severe neurode-
velopmental impairments in long term follow up at 2 years 
(corrected for prematurity) age (Woodward et al., 2006). The 
presence of moderate to severe white matter abnormalities in 
this study was predictive of severe psychomotor delay (10%), 
cerebral palsy (10%), cognitive delay (25%) on Bayley scales of 
Infant Development-II and neurosensory impairment (11%) 
independently of abnormalities on cranial ultrasound imaging. 
Another smaller study which looked at diffusion weighted im-
aging on 38 VLBW infants at term equivalent age found that 
the presence of DEHSI was strongly associated with lower de-
velopmental quotient at 2 years of age (Krishnan et al., 2007). 
In another cohort of 68 preterm infants who had confirmed 
sepsis and or NEC, significant white matter abnormalities were 
noted on brain MRI at term and those infants had poorer psy-
chomotor development at 2 years of age compared to age and 
gestation matched controls without sepsis and or NEC (Shah 
et al., 2008). Evidence of thalamic atrophy, loss of myelination 
especially in posterior limb of internal capsule, and overall loss 
in cortical white matter on MRI imaging are strong predictors 
of development of cerebral palsy and inability of independent 
walking in preterm infants (Inder et al., 1999; Cowan and de 
Vries, 2005; Ricci et al., 2006).
It is noteworthy that some preterm born children with 
white matter abnormalities on MRI were free of severe im-
pairments and had normal motor development at 2 years of 
age in both studies (Woodward et al., 2006; Krishnan et al., 
2007) which accentuates that obtaining brain MRI at term 
equivalent age on prematurely born babies may serve as an 
important screening tool for closer monitoring of babies at 
highest risk of neurodevelopmental impairments but also 
that not all ominous brain MRI findings will translate to se-
vere neurodevelopmental problems in early childhood. This 
highlights the influence of genetics and home environment 
in overcoming the aftermath of prematurity and systemic 
inflammation related comorbidities and determining long 
term neurodevelopmental outcomes.
Potential Therapeutic Interventions: 
Directions of Future Research
All novel interventions and therapies in neonatology must 
go through rigorous evaluation for unexpected long term ad-
verse effects prior to their application in routine practice as the 
vulnerable population of premature babies is in critical phase 
of organ development and maturation. Even though experi-
mental animal data is available for several strategies targeting 
amelioration of systemic inflammation induced cerebral inju-
ry, their application in routine patient management has so far 
been limited. Corticosteroids are potent anti-inflammatory 
agents and dexamethasone use in treatment and prevention of 
chronic lung disease of prematurity is a well prevalent prac-
tice (Doyle et al., 2010). Corticosteroids have been shown to 
modulate chorioamnionitis induced fetal inflammatory state 
in fetal ovine model (Wolfe et al., 2013), however the concern 
of significantly increased risk of cerebral palsy and adverse 
neurodevelopmental outcomes associated with prolonged 
postnatal use of corticosteroids particularly dexamethasone in 
preterm neonates (Wilson-Costello et al., 2009) has prohibited 
its frequent clinical use.
N-acetylecysteine has shown promise as a free radical scav-
enger and antioxidant that has successfully prevented LPS and 
fetal inflammation-induced degeneration of oligodendrocyte 
progenitor cells and myelination defects by attenuating intrace-
rebral inflammatory reaction and TNF, IL-1 and inducible ni-
tric oxide synthase expression in mouse models (Paintlia et al., 
2004; Chang et al., 2011; Beloosesky et al., 2013). Minocycline 
has anti-apoptotic, antioxidant and anti-inflammatory proper-
ties in animal models by diminishing microglial activation and 
maintaining BBB integrity in systemic inflammation associated 
cerebral insult (Stolp et al., 2007). Pentoxifylline, a phosphodi-
esterase inhibitor that increases intracellular cyclic adenosine 
monophosphate levels has protective effects in LPS-induced 
white matter injury in a rat model of PVL (Dilek et al., 2013). 
The drug has a favorable clinical profile in premature neonates 
and is currently being studied as an adjunct therapy to decrease 
mortality and morbidities from sepsis and NEC in premature 
neonates (Pammi and Haque, 2015). 
Studies targeting BBB dysfunction are also being explored. 
Recently, elevated expression of tight junction proteins such 
as claudin-3, 5 and occludins were noted after treatment 
with simvastatin and low molecular weight heparin in ani-
mal models of sepsis resulting in improved selective function 
and decreased permeability of the BBB (Li et al., 2015; Yang 
et al., 2015). Matrix metalloproteinase-2, 9 inhibitors have 
been reported to reverse increases in BBB permeability and 
decrease IL-6 expression in animal model of sepsis related 
BBB dysfunction (Dal-Pizzol et al., 2013). Various immuno-
logical interventions are additionally the subject of ongoing 
research efforts. Systemic administration of a synthetic im-
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mune regulator protein 1018 (innate defense regulator pep-
tide) led to protection against white matter injury in a LPS 
and hypoxia-ischemia induced perinatal brain injury model 
in mice (Bolouri et al., 2014).
Separate from small molecule or protein therapeutics to 
affect preterm infant brain injury are several recent pre-
clinical studies, and some ongoing clinical trials, exploring 
the potential of cell-based treatments (Titomanlio et al., 
2011; Verina et al., 2013; Chicha et al., 2014; Mitsialis and 
Kourembanas, 2016). Most of these studies involve the 
administration of live cells with progenitor/stem-like prop-
erties, with the guise that these cells can multiply to grow 
new tissues replacing the cells damaged from perinatal 
insults, or (more likely) secrete beneficial factors in specific 
brain regions and enhance regional growth in a developing 
organ (Lee et al., 2010; Donega et al., 2015). In many cases 
the preclinical studies support the potential benefits of this 
approach, with the most compelling effects being related 
to direct injections of cell preparations into the lesion (van 
Velthoven et al., 2010a; Mitsialis and Kourembanas, 2016). 
Intranasal delivery has also shown some moderate promise 
(van Velthoven et al., 2010b; Donega et al., 2015). Most data 
strongly support the ‘paracrine-benefit’ mechanism, where-
in the implanted cells release beneficial factors and enhance 
tissue repair (van Velthoven et al., 2010a; van Velthoven et 
al., 2013; Park et al., 2015). Although majority of this inves-
tigation has been done in hypoxic ischemic perinatal brain 
injury setting the final pathogenesis of brain damage in both 
hypoxic ischemic brain injury and systemic inflammatory 
perinatal insult induced brain injury include excitotoxicity 
and oxidative damage in which stem-cell based therapies 
may represent the much awaited answer in the developing 
premature neonate. Studies in this setting have not as yet 
investigated the interactions of these cells with inflammato-
ry pathways that can contribute to tissue remodeling. This 
field is in its very early stages and although there is great 
potential for benefit and somewhat promising results thus 
far, some important hurdles include reliable tissue delivery 
and regulatory challenges in demonstrating long term clini-
cal benefits and avoiding long term disease risks (especially 
cancer, etc.).
Collectively it is clear that there are several therapeutic 
strategies that may have real value in reducing the neuro-
developmental morbidities and major costs associated with 
preterm infant brain injury. For many of these strategies there 
is ample experimental data to support a conceivable effort 
toward clinical investigations and make a substantial impact. 
Given the high prevalence of preterm infant brain injury, and 
its often-devastating consequences, the diligent pursuit of 
newer therapies to enhance outcomes is certainly warranted.
Conclusion
Brain injury in preterm infants is a major medical problem 
and health care cost worldwide; inflammatory mechanisms 
are very likely contributors to nearly all settings and etiolo-
gies. Pertinent knowledge gaps still exist in our detailed un-
derstanding of underlying cytokine mediated mechanisms, 
developmental differences in immune response and complex 
neurovascular barrier system that play a critical role in in 
regulating the cerebral response to systemic inflammatory 
conditions in premature human neonates. A better under-
standing of the dual role of cytokines and balance between 
pro- and anti-inflammatory mediators and its role in brain 
development and maturation is needed to completely ap-
preciate the long term neurodevelopmental consequences 
in this susceptible population. A valid diagnostic cytokine 
profile needs to be designed for biomarkers of perinatal 
brain injury for evaluation in a clinical setting of neonatal 
sepsis, NEC or other systemic inflammatory state. From 
currently available studies white matter abnormality on MRI 
seems to be the anatomic substrate or antecedent for future 
progression to adverse neurodevelopment in a background 
of prematurity and systemic inflammation. Hence, advanced 
brain MR imaging should be considered as part of routine 
care for every premature baby exposed to systemic inflam-
matory conditions in their neonatal course and not just as an 
adjuvant evaluation reserved for babies with severe abnor-
malities on cranial ultrasound imaging at term equivalent 
age. There is now increasing clinical and experimental evi-
dence that systemic inflammatory pathways can damage the 
preterm brain even in absence of direct entry of infectious 
agent to the CNS. Given the high rate of preterm birth and 
huge prevalence of prematurity related inflammatory states 
there is a dire need for development of novel translational 
approaches to alleviate long term neurodevelopmental con-
sequences in this highly vulnerable population. 
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Figure 1 Various mechanisms causing injury to the developing 
brain in systemic inflammatory state.
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